Cargando…
Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial
BACKGROUND: The methods for sentinel lymph node (SLN) biopsy in breast cancer have been variable in type and number of tracers. Some units have abandoned the use of blue dye (BD) due to adverse reactions. Fluorescence-guided biopsy with indocyanine green (ICG) is a relatively novel technique. This s...
Autores principales: | Nguyen, Chu Luan, Zhou, Michael, Easwaralingam, Neshanth, Seah, Jue Li, Azimi, Farhad, Mak, Cindy, Pulitano, Carlo, Warrier, Sanjay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507001/ https://www.ncbi.nlm.nih.gov/pubmed/37402976 http://dx.doi.org/10.1245/s10434-023-13824-6 |
Ejemplares similares
-
ASO Author Reflections: Indocyanine Green Fluorescence Sentinel Lymph Node Biopsy in Breast Cancer—An Alternative to Blue Dye?
por: Nguyen, Chu Luan, et al.
Publicado: (2023) -
Meta-analysis Comparing Fluorescence Imaging with Radioisotope and Blue Dye-Guided Sentinel Node Identification for Breast Cancer Surgery
por: Kedrzycki, Martha S., et al.
Publicado: (2020) -
Comparison of Sentinel Lymph Node Biopsy by Blue Dye Conjunction With Indocyanine Green or Radioisotope in Early-Stage Breast Cancer: A Prospective Single-Center Observational Study
por: Wang, Yanmei, et al.
Publicado: (2023) -
Toward Optimization of Imaging System and Lymphatic Tracer for Near-Infrared Fluorescent Sentinel Lymph Node Mapping in Breast Cancer
por: Mieog, J. Sven D., et al.
Publicado: (2011) -
Randomized Comparison of Near-infrared Fluorescence Imaging Using Indocyanine Green and 99(m) Technetium With or Without Patent Blue for the Sentinel Lymph Node Procedure in Breast Cancer Patients
por: van der Vorst, Joost R., et al.
Publicado: (2012)